{"mainPropery":{"diseaseId":12521,"diseaseName":"IgG4-related disease ","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/12521/igg4-related-disease","synonyms":["IgG4-related systemic disease","IgG4-syndrome","IgG4-associated disease","IgG4-related sclerosing disease","IgG4-related systemic sclerosing disease","IgG4-related autoimmune disease","IgG4-positive multiorgan lymphoproliferative syndrome","Hyper-IgG4 disease","Systemic IgG4-related plasmacytic syndrome","Systemic IgG4-related sclerosing syndrome","Multifocal fibrosclerosis","Multifocal idiopathic fibrosclerosis","Immunoglobulin G4-related sclerosing disease"],"synonyms-with-source":[{"name":"IgG4-related systemic disease","source":"UpToDate"},{"name":"IgG4-syndrome","source":"UpToDate"},{"name":"IgG4-associated disease","source":"UpToDate"},{"name":"IgG4-related sclerosing disease","source":"UpToDate"},{"name":"IgG4-related systemic sclerosing disease","source":"UpToDate"},{"name":"IgG4-related autoimmune disease","source":"UpToDate"},{"name":"IgG4-positive multiorgan lymphoproliferative syndrome","source":"UpToDate"},{"name":"Hyper-IgG4 disease","source":"UpToDate"},{"name":"Systemic IgG4-related plasmacytic syndrome","source":"UpToDate"},{"name":"Systemic IgG4-related sclerosing syndrome","source":"UpToDate"},{"name":"Multifocal fibrosclerosis","source":"UpToDate"},{"name":"Multifocal idiopathic fibrosclerosis","source":"UpToDate"},{"name":"Immunoglobulin G4-related sclerosing disease","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"284264"},{"identifierType":"UMLS","identifierId":"C3203653  "},{"identifierType":"MeSH","identifierId":"101624491"}]},"diseaseCategories":[],"organizations":[],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/pubmed/?term=IgG4-related+disease+%5Bti%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss IgG4-related disease . Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='https://clinicaltrials.gov/ct2/results?term=IgG4-related+disease&Search=Search ' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to IgG4-related disease . Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://www.medscape.com/viewarticle/733608' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=284264' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1550,"resourceId":2178,"resourceName":"DermNet New Zealand","descriptionText":"<a href='http://www.dermnetnz.org/systemic/igg4-disease.html ' target='_blank'>DermNet NZ</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2107,"resourceId":3323,"resourceName":"IgG4-related disease articles","descriptionText":"Khosroshahi A et al.&nbsp;<a href='http://onlinelibrary.wiley.com/doi/10.1002/art.39132/epdf' target='_blank'>International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease</a> Arthritis &amp; Rheumatology. July 2015; 67(7):1688-1699.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":2108,"resourceId":3323,"resourceName":"IgG4-related disease articles","descriptionText":"Pieringer H, Parzer I, Wohrer A, Peis P, Oppl B, Zwerina J.&nbsp;<a href='http://ojrd.biomedcentral.com/articles/10.1186/s13023-014-0110-z' target='_blank'>IgG4-related disease: an orphan with many faces.</a> Orphan Journal of Rare Diseases. 2014; 9:110.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:284264' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2781,"resourceId":4265,"resourceName":"Autoimmune Registry","descriptionText":"The <a href='http://www.autoimmuneregistry.org/' target='_blank'>Autoimmune Registry</a> supports research for IgG4-related disease  by collecting information about patients with this and other autoimmune diseases. You can join the registry to share your information with researchers and receive updates about participating in new research studies.&nbsp;<a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries.</a>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":10647,"questionText":"What is IgG4-related disease?","answerText":"<strong>IgG4-related disease</strong> is an immune-mediated condition that can affect multiple organ systems.[11480][11481][11482][11483] Common features include IgG4-related <a href=\"http://www.mayoclinic.org/diseases-conditions/autoimmune-pancreatitis/basics/definition/con-20034553\" target=\"_blank\">autoimmune pancreatitis</a>, swelling of or within an organ system (an inflammatory pseudotumor), salivary gland disease (which can lead to enlargement of the salivary glands), swollen lymph nodes (<a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/003097.htm\" target=\"_blank\">lymphadenopathy</a>), skin manifestations, and symptoms consistent with allergies or asthma. The cause of IgG4-related disease is unknown. Some researchers believe that it may be an autoimmune or allergic disorder.[11480][11481] IgG4-related disease is usually treated with systemic steroids like <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a601102.html\" target=\"_blank\">prednisone</a>. Immunosuppressive medications (<a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682167.html\" target=\"_blank\">azathioprine</a> or <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a601081.html\" target=\"_blank\">mycophenolate mofetil</a>) and biologics (<a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a607038.html\" target=\"_blank\">rituximab</a> or <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a607007.html\" target=\"_blank\">bortezomib</a>) may be used in those who don't respond to steroids or for longer-term management. In severe cases, organ replacement therapy may be needed.[11480][11481][11482][11483]&nbsp;","dateModified":"2016-05-09T19:21:00"},"basicQuestions":[],"references":[{"referenceId":8732,"authors":"Moutsopoulos HM, Fragoulis GE & Stone JH","articleTitle":"Overview of IgG4-related disease","bookWebsiteJournalTitle":"UpToDate","date":"August 30, 2014","volume":"","pages":"","url":"http://www.uptodate.com/contents/overview-of-igg4-related-disease","dateAccessed":"2015-04-22T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8733,"authors":"Yung A","articleTitle":"IgG4-related disease","bookWebsiteJournalTitle":"Derm Net NZ","date":"March, 2014","volume":"","pages":"","url":"http://www.dermnetnz.org/systemic/igg4-disease.html","dateAccessed":"2015-04-22T00:00:00","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[{"relatedDiseaseId":10911,"relatedDiseaseName":"Autoimmune pancreatitis","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":7043,"relatedDiseaseName":"IgG4-related dacryoadenitis and sialadenitis","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"IgG4-related_disease_"}